Characterization of synergistic antibacterial effect of silver nanoparticles and ebselen.

Author(s) Chen, X.; Chen, H.; Zhang, H.; Peng, Y.; Deng, F.; Gao, J.; Chai, C.; Tang, S.; Zuo, X.; Lu, J.; Du, H.
Journal Artif Cells Nanomed Biotechnol
Date Published 2019 Dec
Abstract

The emerging and spreading of multi-drug resistant (MDR) bacteria have been becoming one of the most severe threats to human health. Enhancing oxidative stress as mimicking immune system was considered as a potential strategy to fight against infection of MDR bacteria. In this study, we investigated the antibacterial efficiency of such a strategy which combines silver nanoparticles (AgNPs) with ebselen. The results showed that AgNPs and ebselen combination had significant synergistic killing effects both on () and () , including model strains of China Veterinary Culture Collection and MDR clinical isolates, which is similar as the combination of silver ion and ebselen. AgNPs exhibited to be a strong inhibitor of bacterial thioredoxin reductase, same as a free silver ion. Ebselen mitigated the cytotoxicity of AgNPs to HeLa cells. However, in a bacteria-cell coexistence condition, the synergistic bactericidal effect was only observed on (<.05), while the temporary synergistic inhibitory effect on within 4 hours treatment (<.01). In mice infection model, a combination of AgNPs and ebselen did not increase protection against the challenge of clinical CQ10 strain. Our data demonstrated that AgNPs and ebselen combination may be a promising strategy to fight against the increasingly MDR bacteria targeting bacterial thiol redox system.

DOI 10.1080/21691401.2019.1648278
ISSN 2169-141X
Citation Artif Cells Nanomed Biotechnol. 2019;47(1):33383349.

Related Applications, Forms & Industries